Crocs, Inc.
Crocs, Inc. (CROX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Crocs, Inc. (CROX), featuring income statements, balance sheets, and cash flow data.
Crocs, Inc. (CROX) Income Statement & Financial Overview
Review Crocs, Inc. CROX income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $937.33M | $989.77M | $1.06B | $1.11B |
| Cost of Revenue | $395.78M | $416.85M | $428.86M | $429.59M |
| Gross Profit | $541.55M | $572.93M | $633.34M | $681.92M |
| Gross Profit Ratio | $0.58 | $0.58 | $0.60 | $0.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $318.57M | $373.01M | $363.51M | $356.18M |
| Operating Expenses | $318.57M | $373.01M | $363.51M | $356.18M |
| Total Costs & Expenses | $714.36M | $789.86M | $792.37M | $785.76M |
| Interest Income | $333000.00 | $576000.00 | $1.37M | $1.13M |
| Interest Expense | $22.77M | $23.34M | $26.20M | $29.16M |
| Depreciation & Amortization | $18.54M | $17.95M | $18.18M | $17.54M |
| EBITDA | $246.24M | $216.52M | $289.29M | $343.13M |
| EBITDA Ratio | $0.26 | $0.22 | $0.27 | $0.31 |
| Operating Income | $222.97M | $199.91M | $269.83M | $325.74M |
| Operating Income Ratio | $0.24 | $0.20 | $0.25 | $0.29 |
| Other Income/Expenses (Net) | -$18.04M | -$24.68M | -$24.93M | -$29.31M |
| Income Before Tax | $204.94M | $175.23M | $244.90M | $296.43M |
| Income Before Tax Ratio | $0.22 | $0.18 | $0.23 | $0.27 |
| Income Tax Expense | $44.84M | -$193.68M | $45.10M | $67.52M |
| Net Income | $160.10M | $368.91M | $199.80M | $228.91M |
| Net Income Ratio | $0.17 | $0.37 | $0.19 | $0.21 |
| EPS | $2.85 | $6.40 | $3.38 | $3.79 |
| Diluted EPS | $2.83 | $6.36 | $3.36 | $3.77 |
| Weighted Avg Shares Outstanding | $56.11M | $57.62M | $59.05M | $60.32M |
| Weighted Avg Shares Outstanding (Diluted) | $56.50M | $58.03M | $59.50M | $60.77M |
The company's financials show resilient growth, with revenue advancing from $1.11B in Q2 2024 to $937.33M in Q1 2025. Gross profit remained healthy with margins at 58% in Q1 2025 compared to 61% in Q2 2024. Operating income hit $222.97M last quarter, sustaining a consistent 24% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $246.24M. Net income dropped to $160.10M, while earnings per share reached $2.85. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan